BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 20846095)

  • 1. Therapy-related myelodysplastic syndrome/acute myeloid leukemia following fludarabine therapy for non-Hodgkin lymphoma and chronic lymphocytic leukemia in Thai patients.
    Niparuck P; Kanoksil W; Chuncharunee S; Boonsakan P; Ungkanont A; Angchaisuksiri P; Karntisaviwat K; Apilugsanachit A; Rerkamnuatchoke B; Jootar S; Nitiyanant P; Atichartakarn V
    Leuk Lymphoma; 2010 Nov; 51(11):2120-5. PubMed ID: 20846095
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute myeloid leukemia and myelodysplasia in patients with chronic lymphocytic leukemia receiving fludarabine as initial therapy.
    Coso D; Costello R; Cohen-Valensi R; Sainty D; Nezri M; Gastaut JA; Bouabdallah R
    Ann Oncol; 1999 Mar; 10(3):362-3. PubMed ID: 10355587
    [No Abstract]   [Full Text] [Related]  

  • 3. Myelodysplastic syndrome and acute myeloid leukemia after treatment with fludarabine, mitoxantrone, and dexamethasone.
    Au WY; Chan LC; Liang R; Kwong YL
    Am J Hematol; 2006 Jun; 81(6):471-3. PubMed ID: 16680740
    [No Abstract]   [Full Text] [Related]  

  • 4. Second cancers in patients with chronic lymphocytic leukemia who received frontline fludarabine, cyclophosphamide and rituximab therapy: distribution and clinical outcomes.
    Benjamini O; Jain P; Trinh L; Qiao W; Strom SS; Lerner S; Wang X; Burger J; Ferrajoli A; Kantarjian H; O'Brien S; Wierda W; Estrov Z; Keating M
    Leuk Lymphoma; 2015 Jun; 56(6):1643-50. PubMed ID: 25308294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapy-related myelodysplastic syndrome and acute myeloid leukemia in patients with chronic lymphocytic leukemia treated with fludarabine and cyclophosphamide.
    Colović M; Suvajdžić N; Janković G; Tomin D; Colović N; Fekete MD; Palibrk V
    Biomed Pharmacother; 2011 Aug; 65(5):319-21. PubMed ID: 21775097
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following fludarabine combination chemotherapy.
    Carney DA; Westerman DA; Tam CS; Milner A; Prince HM; Kenealy M; Wolf M; Januszewicz EH; Ritchie D; Came N; Seymour JF
    Leukemia; 2010 Dec; 24(12):2056-62. PubMed ID: 20962860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-related myeloid leukemias are observed in patients with chronic lymphocytic leukemia after treatment with fludarabine and chlorambucil: results of an intergroup study, cancer and leukemia group B 9011.
    Morrison VA; Rai KR; Peterson BL; Kolitz JE; Elias L; Appelbaum FR; Hines JD; Shepherd L; Larson RA; Schiffer CA
    J Clin Oncol; 2002 Sep; 20(18):3878-84. PubMed ID: 12228208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy-related acute myeloid leukaemia and myelodysplastic syndrome in Victoria, Australia 2003-2014.
    Ong DM; Farrugia H; Wei A
    Intern Med J; 2018 Jul; 48(7):822-829. PubMed ID: 29236346
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapy-related leukemia and myelodysplastic syndrome in chronic lymphocytic leukemia.
    Robertson LE; Estey E; Kantarjian H; Koller C; O'Brien S; Brown B; Keating MJ
    Leukemia; 1994 Dec; 8(12):2047-51. PubMed ID: 7807993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapy-related acute myeloid leukemia after single-agent treatment with fludarabine for chronic lymphocytic leukemia.
    Lam CC; Ma ES; Kwong YL
    Am J Hematol; 2005 Aug; 79(4):288-90. PubMed ID: 16044456
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fludarabine-related hemolytic anemia in chronic lymphocytic leukemia and lymphoproliferative disorders.
    Taha HM; Narasihman P; Venkatesh L; Cawley M; Kaplan B
    Am J Hematol; 1998 Dec; 59(4):316. PubMed ID: 9840913
    [No Abstract]   [Full Text] [Related]  

  • 12. Second cancers in chronic lymphocytic leukemia: growing importance in the era of improved treatment outcomes.
    Langerbeins P; Maurer C; Cramer P; Eichhorst B; Hallek M
    Leuk Lymphoma; 2015 Jun; 56(6):1575-6. PubMed ID: 25804766
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical characteristics and prognosis of 35 patients with therapy-related hematological neoplasms].
    Lu QS; Xu N; Zhou X; Cai GX; Li L; Li YL; Lu ZY; Huang JX; Liu QF; Liu XL
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):221-6. PubMed ID: 27033760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of treatment-related myelodysplastic syndromes and acute myeloid leukemia in patients with non-Hodgkin lymphoma treated with tositumomab and iodine I131 tositumomab.
    Bennett JM; Kaminski MS; Leonard JP; Vose JM; Zelenetz AD; Knox SJ; Horning S; Press OW; Radford JA; Kroll SM; Capizzi RL
    Blood; 2005 Jun; 105(12):4576-82. PubMed ID: 15731177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of new malignancies among patients with CLL treated with chemotherapy: results of a Danish population-based study.
    da Cunha-Bang C; Rostgaard K; Andersen MA; Rotbain EC; Grønbaek K; Frederiksen H; Niemann CU; Hjalgrim H
    Br J Haematol; 2021 Apr; 193(2):339-345. PubMed ID: 33570184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phase I study of bryostatin-1 and fludarabine in patients with chronic lymphocytic leukemia and indolent non-Hodgkin's lymphoma.
    Roberts JD; Smith MR; Feldman EJ; Cragg L; Grant S
    Clin Lymphoma; 2002 Dec; 3(3):184-8. PubMed ID: 12521398
    [No Abstract]   [Full Text] [Related]  

  • 17. Therapy-related acute myeloid leukemia and myelodysplastic syndrome among refractory germ cell tumor patients.
    Inoue Y; Nakamura T; Nakanishi H; Oishi M; Hongo F; Okihara K; Mizutani S; Kuroda J; Ukimura O
    Int J Urol; 2018 Jul; 25(7):678-683. PubMed ID: 29752743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fludarabine-related myeloid leukemia.
    Astrow AB
    J Clin Oncol; 2003 Oct; 21(19):3709; author reply 3709-10. PubMed ID: 14512411
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapy-related myelodysplastic syndrome and acute myeloid leukemia following initial treatment with chemotherapy plus radioimmunotherapy for indolent non-Hodgkin lymphoma.
    Roboz GJ; Bennett JM; Coleman M; Ritchie EK; Furman RR; Rossi A; Jhaveri K; Feldman EJ; Leonard JP
    Leuk Res; 2007 Aug; 31(8):1141-4. PubMed ID: 17475326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fludarabine in the treatment of lymphoproliferative malignancies.
    Feldman EJ; Keating MJ
    Cancer Invest; 1993; 11(3):314-8. PubMed ID: 8485654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.